First-in-Class KRAS-Degrader Promising in Pancreatic, Lung Cancers
(MedPage Today) -- Setidegrasib showed promising efficacy in patients with previously treated advanced KRAS G12D-mutated pancreatic ductal adenocarcinoma (PDAC) or ...
(MedPage Today) -- Setidegrasib showed promising efficacy in patients with previously treated advanced KRAS G12D-mutated pancreatic ductal adenocarcinoma (PDAC) or ...
(MedPage Today) -- Interval colorectal cancers (CRCs) were lower when patients' endoscopists had a better sessile serrated lesion detection rate ...
Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve ...
(MedPage Today) -- The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy ...
Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat. Northwestern ...
(MedPage Today) -- SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers have now uncovered ...
Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, ...
Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.